Navigation Links
Stereotaxis Epoch™ Solution's Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
Date:5/7/2012

ST. LOUIS, May 7, 2012 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ:   STXS) will highlight clinical results from the first 1,250 cases and the latest innovations for the Epoch™ platform, its new generation comprehensive solution for the electrophysiology (EP) laboratory, at the 33rd Annual Heart Rhythm Society (HRS) Scientific Sessions, May 9-12, 2012. 

The formal HRS academic program features multiple invited presentations, podium presentations, and posters detailing Stereotaxis' clinical results in a wide variety of arrhythmias. A total of 11 invited podium presentations feature use of Stereotaxis magnetic navigation technology.   In addition, 13 submitted abstracts that feature or discuss Stereotaxis technology are included in this year's HRS program.  Highlights of these submitted abstracts include comparative data on VT ablation, multi-center VT data, lesion formation, pediatric outcome data, and the first large series of Vdrive™ system's clinical outcomes data.

Stereotaxis will be at booth number 1307, providing demonstrations of commercially available products and a technical suite for obtaining input on new product innovations from select physician customers.  In addition, the Company will feature at the booth a speaker series where customers will share their experiences with the Epoch™ and Odyssey™ product platforms.  In-booth speakers include:

  • Dr. Robert Schweikert from Akron General Medical Center on the Odyssey™ Solution (May 10 at 9:30 am ET);
  • Dr. Yaariv Khaykin from Southlake Regional Health Center on the Odyssey™ Solution (May 10 at 10:00 am ET); and
  • Dr. J. Peter Weiss from Intermountain Medical Center on the Epoch™ Solution (May 10 at 3:45 pm ET and May 11 at 10:00 am ET). 

Stereotaxis will unveil a broad number of product innovations for the Niobe® ES, Vdrive™ and Od
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012
2. Stereotaxis Reports 2011 Financial Results; Provides 2012 Milestones
3. Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012
4. Stereotaxis Announces Initial Shipments of the Epoch™ Platform to Customers
5. Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Stereotaxis Reports Third Quarter Financial Results
7. Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011
8. Stereotaxis to Present at the JMP Securities Healthcare Conference on September 28, 2011
9. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
10. Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011
11. Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ... Grade Sodium Chloride Market by Applications, by Region - ... their offering. The pharmaceutical grade sodium chloride ... between 2014 and 2019 in terms of volume, and ... 2019. The report on Pharmaceutical grade sodium ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... 6, 2015 Akcea Therapeutics, a wholly-owned ... ), announced today that the U.S. Food and ... volanesorsen (ISIS-APOCIII Rx ) for the treatment of ... a rare genetic disease characterized by extremely high ... Phase 2 study published in the NEJM in ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... Oct. 7 Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical ... A. Weinberg, Ph.D., a founding member of the Whitehead ... at MIT, has joined the company,s Scientific Advisory Board. ... first human oncogene (the ras oncogene that ...
... MAARSSEN, The Netherlands, Oct. 7 CPhI Worldwide ... largest annual meeting - returns to Madrid on 12 - 15 ... contract services and P-MEC equipment and technology events ... banner by the new, biotech-focused BioPh . The new ...
Cached Medicine Technology:Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 3CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 2CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 3
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in the realm ... the Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana ... persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart ...
(Date:7/7/2015)... Chicago, Illinois (PRWEB) , ... July 07, 2015 ... ... in government program modernization, today announced they have been selected by the Department ... Validation (IV&V) services for its Medicaid Management Information System (MMIS) and Integrated Contact ...
(Date:7/6/2015)... ... July 06, 2015 , ... Respected southern California personal injury ... 2015, marking him as an attorney who has sharp legal skills as well as ... Distinction Award for 2015 from Martindale-Hubbell and a Top 10 Award from The National ...
(Date:7/6/2015)... , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair ... they turn age 35 a quarter of all women in the U.S. will suffer from ... is stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed for ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... The Asian-Pacific ... in 2014. It is expected to grow at a CAGR of over 3.2 percent ... , The growth is likely to be mainly spurred by an anticipated launch of ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
... in order to show- how eating patterns can stop you getting ... 60 or over living in many countries . They have ... lots of green leafy vegetables, beans, olive oil, nuts and multigrain ... and sugar was also linked to keeping a smoother skin.// ...
... brain power, according to Japanese research. ,It is thought ... or restrict the hardening of the arteries which could ... ,However, there are other factors linked to moderate ... IQ. The researchers, at the National Institute for Longevity ...
... of mouthwash is being hailed as a new weapon against ... some deodorants, seems to be able to prevent the growth ... of mosquitoes which causes as many as 3.2m deaths worldwide ... the agent has yet to be fully developed, the increasing ...
... India has finally decided to get its act together on ... get a large number of laboratories activated on testing them, ... plants to ensure the raw material itself meets standards. The ... a series of measures to boost the medicinal plants sector. ...
... is an effective treatment for neuropathic pain (nerve pain).,Neuropathic ... tricyclic antidepressants(TCAs) But these drugs have side effects ... sensations associated with nerve pain. ,Now researchers ... SR (sustained release) is effective against nerve pain in ...
... lupus erythematosus (SLE)--usually referred to simply as lupus--is the ... by inflammation and damage to tissue and organs throughout ... central nervous system. Lupus is an autoimmune disorder, meaning ... ,New research into lupus suggests how the immune ...
Cached Medicine News:
... cleanser will not leave your hands dry, ... With persistent Antimicrobial action, CHG Skin Cleanser ... gram-negative and gram-positive bacteria, fungi, and yeasts. ... second hand wash. The solution does not ...
IV Prep Antiseptic Wipes are effective and easy to apply. They are ideal for preparation of the skin prior to a ventipuncture or injection....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Skin Protectant Swabsticks prepare ... dressing or bandage. When dry, they leave ... This provides a clean surface and a ... affect the adhesion of a dressing or ...
Medicine Products: